BIOMARIN PHARMACEUTICAL INC Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for June 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,100 | 0 | 21,400 | 19.3 K to 21.4 K (+10.88 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Option Exercise | A | 63.10 | 1,500 | 94,650 | 1,500 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 525 | 0 | 5,225 | 4.7 K to 5.2 K (+11.17 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Grant | A | 0.00 | 2,100 | 0 | 24,150 | 22.1 K to 24.2 K (+9.52 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | YOUNG WILLIAM D | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 2,100 | 0 | 10,775 | 8.7 K to 10.8 K (+24.21 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 2,100 | 0 | 11,800 | 9.7 K to 11.8 K (+21.65 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Grant | A | 0.00 | 2,100 | 0 | 30,150 | 28.1 K to 30.2 K (+7.49 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 2,100 | 0 | 19,525 | 17.4 K to 19.5 K (+12.05 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | BATE KENNETH | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | BATE KENNETH | Director | Grant | A | 0.00 | 2,100 | 0 | 10,775 | 8.7 K to 10.8 K (+24.21 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | A | 63.10 | 58,400 | 3,685,040 | 58,400 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 15,600 | 0 | 76,550 | 61 K to 76.6 K (+25.59 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 2,100 | 0 | 25,150 | 23.1 K to 25.2 K (+9.11 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | A | 63.10 | 47,200 | 2,978,320 | 47,200 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 12,600 | 0 | 99,200 | 86.6 K to 99.2 K (+14.55 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | A | 63.10 | 42,700 | 2,694,370 | 42,700 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Grant | A | 0.00 | 11,400 | 0 | 31,590 | 20.2 K to 31.6 K (+56.46 %) |
Jun 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 57.96 | 297 | 17,214 | 7,993 | 8.3 K to 8 K (-3.58 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | A | 63.10 | 51,700 | 3,262,270 | 51,700 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 13,800 | 0 | 73,134 | 59.3 K to 73.1 K (+23.26 %) |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 63.10 | 191,000 | 12,052,100 | 191,000 | |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 50,900 | 0 | 229,157 | 178.3 K to 229.2 K (+28.55 %) |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 62.52 | 1,000 | 62,521 | 178,257 | 179.3 K to 178.3 K (-0.56 %) |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 59.88 | 1,000 | 59,876 | 179,257 | 180.3 K to 179.3 K (-0.55 %) |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Option Exercise | A | 63.10 | 42,700 | 2,694,370 | 42,700 | |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Grant | A | 0.00 | 11,400 | 0 | 64,426 | 53 K to 64.4 K (+21.50 %) |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Sell | D | 60.00 | 3,562 | 213,720 | 53,026 | 56.6 K to 53 K (-6.29 %) |
Jun 05 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Gift | G | 23.21 | 180 | 4,178 | 56,588 | 56.8 K to 56.6 K (-0.32 %) |
Jun 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 57.83 | 377 | 21,804 | 20,190 | 20.6 K to 20.2 K (-1.83 %) |
Jun 02 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 57.96 | 413 | 23,937 | 20,567 | 21 K to 20.6 K (-1.97 %) |
Jun 02 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 57.50 | 3,792 | 218,040 | 59,334 | 63.1 K to 59.3 K (-6.01 %) |